Traub Capital Management’s Pfizer PFE Stock Holding History

Traub Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$621K	Buy	25,792 +6	+0%	+$157	0.55%	45
2026 Q1	$724K	Sell	25,786 -448	-2%	-$11.9K	0.72%	35
2025 Q4	$653K	Buy	26,234 +2,016	+8%	+$50.8K	0.63%	45
2025 Q3	$617K	Sell	24,218 -1,850	-7%	-$45.7K	0.61%	44
2025 Q2	$632K	Buy	+26,068	New	+$608K	0.58%	42

Other funds holding PFE

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Traub Capital Management's PFE Position: Q2 2026 in Review

Traub Capital Management increased its Pfizer (PFE) stake by 0.02% in Q2 2026, buying an estimated $157 and bringing the position to 25,792 shares worth $621K. The position accounts for 0.55% of the portfolio, ranked #45.

Traub Capital Management first reported a position in PFE in Q2 2025 and has held it in 5 quarters since. The position peaked at $724K in Q1 2026. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Traub Capital Management held 25,792 shares of Pfizer worth $621K as of Q2 2026.
Traub Capital Management bought 6 Pfizer shares in Q2 2026, an estimated $157.
Pfizer made up 0.55% of Traub Capital Management's portfolio in Q2 2026, its #45 holding.
Traub Capital Management first reported a position in Pfizer in Q2 2025 and has held it in 5 quarters since.
Traub Capital Management's Pfizer position peaked at $724K in Q1 2026.
900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Traub Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.